Kirill Veselkov
Cards
About
Research
Publications
P695 Untargeted proteomics analysis of baseline serum samples prior to biologic therapy initiation
Rauch M, Laponogov I, van Welsen I, Quinn A, Joustra V, Paulich H, Perez B, Ramkisoen R, Noble A, Satsangi J, D’Haens G, Williamson A, Veselkov K, van 't Wout A. P695 Untargeted proteomics analysis of baseline serum samples prior to biologic therapy initiation. Journal Of Crohn's And Colitis 2024, 18: i1316-i1317. DOI: 10.1093/ecco-jcc/jjad212.0825.Peer-Reviewed Original ResearchAnti-TNFa treatmentAnti-TNFaSerum proteomic profilesTreatment outcomesCrohn's diseaseTreatment responseNon-respondersCD patientsBiological drugsModerate to severe CDSerum collectionSustained clinical responseFirst-line therapyBaseline serum samplesProteomic profilingBiobanked serum samplesBiologic treatment outcomesSevere CD patientsSerum samplesBiologic treatment responseStandard of careSerum proteomic analysisClinical responseStratify patientsSevere CD